Cargando…
Management of Post-transplant Hyperparathyroidism and Bone Disease
Significant advances in immunosuppressive therapies have been made in renal transplantation, leading to increased allograft and patient survival. Despite improvement in overall patient survival, patients continue to require management of persistent post-transplant hyperparathyroidism. Medications th...
Autores principales: | Delos Santos, Rowena, Rossi, Ana, Coyne, Daniel, Maw, Thin Thin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439149/ https://www.ncbi.nlm.nih.gov/pubmed/30811012 http://dx.doi.org/10.1007/s40265-019-01074-4 |
Ejemplares similares
-
The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism
por: Patel, Rima, et al.
Publicado: (2020) -
The Privilege of Induction Avoidance and Calcineurin Inhibitors Withdrawal in 2 Haplotype HLA Matched White Kidney Transplantation
por: Brifkani, Zaid, et al.
Publicado: (2017) -
Viral Respiratory Tract Infections in Transplant Patients: Epidemiology, Recognition and Management
por: Lee, Ingi, et al.
Publicado: (2012) -
High-dose hydroxocobalamin in end-stage liver disease and liver transplantation
por: Sakpal, Sujit Vijay, et al.
Publicado: (2019) -
Management of Hypertension in Chronic Kidney Disease
por: Pugh, Dan, et al.
Publicado: (2019)